Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Microbiology

  • Subscribe to feed (RSS)

Showing page 116 of 255 pages of list content

  • Virological characteristics of SARS-CoV-2 BA.2 variant

    This article's authors
    1. Daichi Yamasoba
    2. Izumi Kimura
    3. Hesham Nasser
    4. Yuhei Morioka
    5. Naganori Nao
    6. Jumpei Ito
    7. Keiya Uriu
    8. Masumi Tsuda
    9. Jiri Zahradnik
    10. Kotaro Shirakawa
    11. Rigel Suzuki
    12. Mai Kishimoto
    13. Yusuke Kosugi
    14. Kouji Kobiyama
    15. Teppei Hara
    16. Mako Toyoda
    17. Yuri L Tanaka
    18. Erika P Butlertanaka
    19. Ryo Shimizu
    20. Hayato Ito
    21. Lei Wang
    22. Yoshitaka Oda
    23. Yasuko Orba
    24. Michihito Sasaki
    25. Kayoko Nagata
    26. Kumiko Yoshimatsu
    27. Hiroyuki Asakura
    28. Mami Nagashima
    29. Kenji Sadamasu
    30. Kazuhisa Yoshimura
    31. Jin Kuramochi
    32. Motoaki Seki
    33. Ryoji Fujiki
    34. Atsushi Kaneda
    35. Tadanaga Shimada
    36. Taka-aki Nakada
    37. Seiichiro Sakao
    38. Takuji Suzuki
    39. Takamasa Ueno
    40. Akifumi Takaori-Kondo
    41. Ken J Ishii
    42. Gideon Schreiber
    43. The Genotype to Phenotype Japan (G2P-Japan) Consortium
    44. Hirofumi Sawa
    45. Akatsuki Saito
    46. Takashi Irie
    47. Shinya Tanaka
    48. Keita Matsuno
    49. Takasuke Fukuhara
    50. Terumasa Ikeda
    51. Kei Sato
    This article has 1 evaluations Latest evaluation on Feb 18, 2022 Published on Feb 15, 2022
  • Oral administration of S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and accelerates recovery from clinical aspects of COVID-19

    This article's authors
    1. Michihito Sasaki
    2. Koshiro Tabata
    3. Mai Kishimoto
    4. Yukari Itakura
    5. Hiroko Kobayashi
    6. Takuma Ariizumi
    7. Kentaro Uemura
    8. Shinsuke Toba
    9. Shinji Kusakabe
    10. Yuki Maruyama
    11. Shun Iida
    12. Noriko Nakajima
    13. Tadaki Suzuki
    14. Shinpei Yoshida
    15. Haruaki Nobori
    16. Takao Sanaki
    17. Teruhisa Kato
    18. Takao Shishido
    19. William W. Hall
    20. Yasuko Orba
    21. Akihiko Sato
    22. Hirofumi Sawa
    This article has 1 evaluations Latest evaluation on Feb 18, 2022 Published on Feb 15, 2022
  • A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions

    This article's authors
    1. Yang Liu
    2. Xianwen Zhang
    3. Jianying Liu
    4. Hongjie Xia
    5. Jing Zou
    6. Antonio E. Muruato
    7. Sivakumar Periasamy
    8. Jessica A. Plante
    9. Nathen E. Bopp
    10. Chaitanya Kurhade
    11. Alexander Bukreyev
    12. Ping Ren
    13. Tian Wang
    14. Menachery Vineet D.
    15. Kenneth S. Plante
    16. Xuping Xie
    17. Scott C. Weaver
    18. Pei-Yong Shi
    This article has 1 evaluations Latest evaluation on Feb 17, 2022 Published on Feb 15, 2022
  • SARS-CoV-2 Permissive Glioblastoma Cell Line for High Throughput Antiviral Screening

    This article's authors
    1. Emiel Vanhulle
    2. Joren Stroobants
    3. Becky Provinciael
    4. Anita Camps
    5. Sam Noppen
    6. Piet Maes
    7. Kurt Vermeire
    This article has 1 evaluations Latest evaluation on Feb 16, 2022 Published on Feb 14, 2022
  • Malaria parasites utilize pyrophosphate to fuel an essential proton pump in the ring stage and the transition to trophozoite stage

    This article's authors
    1. Omobukola Solebo
    2. Liqin Ling
    3. Jing Zhou
    4. Tian-Min Fu
    5. Hangjun Ke
    This article has 5 evaluations Latest evaluation on Jan 2, 2023 Published on Dec 19, 2021
  • In Vitro Selection of Remdesivir-Resistant SARS-CoV-2 Demonstrates High Barrier to Resistance

    This article's authors
    1. Liva Checkmahomed
    2. Venice Du Pont
    3. Nicholas C. Riola
    4. Jason K. Perry
    5. Jiani Li
    6. Danielle P. Porter
    7. Guy Boivin
    This article has 1 evaluations Latest evaluation on Feb 15, 2022 Published on Feb 12, 2022
  • Remdesivir and GS-441524 retain antiviral activity against Delta, Omicron, and other emergent SARS-CoV-2 variants

    This article's authors
    1. Jared Pitts
    2. Jiani Li
    3. Jason K. Perry
    4. Venice Du Pont
    5. Nicholas Riola
    6. Lauren Rodriguez
    7. Xianghan Lu
    8. Chaitanya Kurhade
    9. Xuping Xie
    10. Gregory Camus
    11. Savrina Manhas
    12. Ross Martin
    13. Pei-Yong Shi
    14. Tomas Cihlar
    15. Danielle P. Porter
    16. Hongmei Mo
    17. Evguenia Maiorova
    18. John P. Bilello
    This article has 1 evaluations Latest evaluation on Feb 14, 2022 Published on Feb 10, 2022
  • Dual Inhibition of Cathepsin L and 3CL-Pro by GC-376 Constrains SARS Cov2 Infection Including Omicron Variant

    This article's authors
    1. Prabhakaran Kumar
    2. Kiira M Ratia
    3. Justin M Richner
    4. Gregory R J Thatcher
    5. Rashmi Kadam
    6. Sandra P Smieszek
    7. Bartlomiej P Przychodzen
    8. Vuk Koprivica
    9. Gunther Birznieks
    10. Mihael H Polymeropoulos
    11. Bellur S Prabhakar
    This article has 1 evaluations Latest evaluation on Feb 14, 2022 Published on Feb 10, 2022
  • Host casein kinase 1-mediated phosphorylation modulates phase separation of a rhabdovirus phosphoprotein and virus infection

    This article's authors
    1. Xiao-Dong Fang
    2. Qiang Gao
    3. Ying Zang
    4. Ji-Hui Qiao
    5. Dong-Min Gao
    6. Wen-Ya Xu
    7. Ying Wang
    8. Dawei Li
    9. Xian-Bing Wang
    This article has 5 evaluations Latest evaluation on Feb 14, 2022 Published on Nov 16, 2021
  • Noisy metabolism can drive the evolution of microbial cross-feeding

    This article's authors
    1. Jaime G. Lopez
    2. Ned S. Wingreen
    This article has 5 evaluations Latest evaluation on Feb 13, 2022 Published on Jun 2, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information